Response definition criteria for ELISPOT assays revisited
Zoe Moodie(Fred Hutch Cancer Center), Cedrik M. Britten(Johannes Gutenberg University Mainz), Sylvia Janetzki(Yale University), Marij J.P. Welters(Leiden University Medical Center), Christian H. Ottensmeier(Clatterbridge Cancer Centre NHS Foundation Trust), Leah Price(Cwm Taf University Health Board), Ann Mander(NIHR CRUK Experimental Cancer Medicine Centre), Cécile Gouttefangeas(University of Tübingen), Martin Löwer, Sjoerd H. van der Burg(Leiden University Medical Center)
Cited by 231
Related Papers
Therapeutic cancer vaccines
|Journal of Clinical Investigation|2015|1.1k
Cancer classification using the Immunoscore: a worldwide task force
|Journal of Translational Medicine|2012|803
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis
|The Lancet|2008|708